Wanner, C., Nangaku, M., Kraus, B. J., Zinman, B., Mattheus, M., Hantel, S., Schumacher, M., Ohneberg, K., Schmoor, C., & Inzucchi, S. E. [ca. 2024]. How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trial [Cd]. Freiburg: Universität. https://doi.org/10.1093/ndt/gfae032
ISO-690 (author-date, English)WANNER, Christoph, NANGAKU, Masaomi, KRAUS, Bettina J, ZINMAN, Bernard, MATTHEUS, Michaela, HANTEL, Stefan, SCHUMACHER, Martin, OHNEBERG, Kristin, SCHMOOR, Claudia und INZUCCHI, Silvio E., 2024. How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trial. Freiburg: Universität.
Modern Language Association 9th editionWanner, C., M. Nangaku, B. J. Kraus, B. Zinman, M. Mattheus, S. Hantel, M. Schumacher, K. Ohneberg, C. Schmoor, und S. E. Inzucchi. How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trial. cd, Universität, 2024, https://doi.org/10.1093/ndt/gfae032.
Mohr Siebeck - Recht (Deutsch - Österreich)Wanner, Christoph/Nangaku, Masaomi/Kraus, Bettina J/Zinman, Bernard/Mattheus, Michaela/Hantel, Stefan u. a.: How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trial, Freiburg 2024.
Emerald - HarvardWanner, C., Nangaku, M., Kraus, B.J., Zinman, B., Mattheus, M., Hantel, S., Schumacher, M., Ohneberg, K., Schmoor, C. und Inzucchi, S.E. (2024), How do SGLT2 inhibitors protect the kidney? A mediation analysis of the EMPA-REG OUTCOME trial, Bd. , Universität, Freiburg, verfügbar unter:https://doi.org/10.1093/ndt/gfae032.